NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
106 hedge funds and large institutions have $124M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 41 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-16
Holders Change %
-13.11%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
11
Increased
41
Reduced
38
Closed
27
Calls
$33K
Puts
$3K
Net Calls
+$30K
Net Calls Change
-$85K
Top Buyers
| 1 |
BlackRock
New York
|
$12M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$1.52M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$897K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
$2.95M |
| 5 |
State Street
Boston,
Massachusetts
|
$2.22M |
